Showing 1 - 3 results of 3 for search 'Adriana T Larregina', query time: 0.02s Refine Results
  1. 1
    In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy.

    In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. by Zhiliang Wang, William J Shufesky, Angela Montecalvo, Sherrie J Divito, Adriana T Larregina, Adrian E Morelli

    Published 2009-01-01
    Get full text
    Article
  2. 2
    Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.

    Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. by Ximena D Ruiz, Logan R Mlakar, Yukie Yamaguchi, Yunyun Su, Adriana T Larregina, Joseph M Pilewski, Carol A Feghali-Bostwick

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Neurokinin-1 Receptor Signaling Is Required for Efficient Ca2+ Flux in T-Cell-Receptor-Activated T Cells

    Neurokinin-1 Receptor Signaling Is Required for Efficient Ca2+ Flux in T-Cell-Receptor-Activated T Cells by Adrian E. Morelli, Tina L. Sumpter, Darling M. Rojas-Canales, Mohna Bandyopadhyay, Zhizhao Chen, Olga Tkacheva, William J. Shufesky, Callen T. Wallace, Simon C. Watkins, Alexandra Berger, Christopher J. Paige, Louis D. Falo, Jr., Adriana T. Larregina

    Published 2020-03-01
    Get full text
    Article

Search Tools: